Zurex Pharma, Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Middleton Wisconsin United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2014
NCT02160574
First Marketed Drug
2019
isopropyl alcohol
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ZUREX PHARMA | Zurex Pharma, Inc.

Active Ingredients

Marketed Drugs (1)

isopropyl alcohol (2019)

Drugs in Phase 3 Trials (4)

chlorhexidine (hibitane) (9 trials)

iodine povacrylex (DuraPrep Surgical) (5 trials)

isopropyl alcohol (2 trials)

sodium chloride (3 trials)

Drugs in Phase 1 Trials (1)

sodium monododecyl sulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Surgical Wound Infection (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 5